The German Constitutional Court has published its decision that the German Act implementing the Unified Patent Court system is unconstitutional.
After a long drawn out process and admittedly some flaws in this project, the German courts put a major halt on hopes of a unified patent or unified patent court (UPC). While, they did agree to re-evaluate the UPC after Brexit, it seems that the reality of a UP or UPC, has been buried for years to come. Says co-head of IP law firm Fieldfisher Benjamin Grizimek.
Germany was the final nail in the coffin, after many other countries had ratified the creation of a UPC. Germany understandably played leading role in the decision especially as within Europe, Germany is the largest filer of patents and the majority of patent litigation also takes place in the German courts, he noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze